Oncodesign, a pioneer in precision medicine

A philosophy rooted in technological innovation

Since 1995, Oncodesign has been innovating to discover new therapies for cancers and diseases with no known treatment.

Scientific and commercial support for drug discovery

Integrated services in drug discovery | Service BU

Integrated services in drug discovery | Service BU

State-of-the-art expertise available throughout the whole process, from hit finding to the IND, so you can discover and test your innovative therapies

Innovative technological approaches by the Biotech BU - Oncodesign

Innovative technological approaches | Biotech BU

Innovative technologies and partnerships so your therapeutic programs can make progress

AI BU - Artificial Intelligence to support precision medicine - Oncodesign

Artificial Intelligence tools | AI BU

Hybrid AI and Drug Discovery expertise for a faster and more reliable drug candidate search process

Homing Program - An alliance to make your drug development in oncology a success

Homing : a preclinical co-development program for your molecule

Combined expertise to speed up your oncology and immuno-oncology research & development programs

Innovation model at Oncodesign, a combination of Etiology, Discovery and Experimentation centered on the patient

Our innovation technologies optimize your drug discovery programs to make them faster and more reliable

For more than 25 years, Oncodesign has been investing in precision medicine research technologies, which are essential from the very first stages of the Drug Discovery process. Our technology modules allow a continuum from molecule to patient, with the goal of discovering new treatments for patients with no therapeutic options.

Science within easy reach!

Science within easy reach!

Receive our monthly general newsletters or our biannual shareholder newsletter.

Our latest resources

Our latest resources

24/02/2022

Abzena x Alira Health x Oncodesign: unveil unique integrated solution with specialist services, from biologics discovery to clinical & commercial manufacturing

Read more
08/02/2022

Read all the details of the collaboration agreement for R&D of a new personalized cancer treatment for aggressive and untreatable tumors.

Read more